Literature DB >> 30806572

Syntheses, characterization, DNA/HSA binding ability and antitumor activities of a family of isostructural binuclear lanthanide complexes containing hydrazine Schiff base.

Xue-Qing Song1, Zhi-Gang Wang1, Yang Wang1, Yu-Ying Huang1, Yu-Xuan Sun1, Yan Ouyang1,2, Cheng-Zhi Xie1,2, Jing-Yuan Xu1.   

Abstract

Three dinuclear lanthanide complexes, [Ln2(L)2(μ3-OAc)4(H2O)2]⋅2H2O (Ln = La (1), Eu (2) and Dy (3), HL = N'-(2-hydroxybenzylidene) nicotinohydrazide), have been synthesized and characterized by IR, elemental analysis and X-ray single-crystal diffraction. Crystallographic study revealed that the representative complex 1 displays a discrete dinuclear structure with a distorted tricapped trigonal prismatic geometry around La(III) ion. The interaction of complexes 1-3 with CT-DNA was investigated by absorption spectra, fluorescence quenching and viscosity, which reveals that the complexes bind to CT-DNA with a moderate intercalative mode. The complexes exhibited obvious DNA cleavage activities in the presence of H2O2. All complexes could bind to human serum albumin (HSA) with medium affinity through static mode; thus, HSA could effectively transport complexes. Furthermore, three complexes exhibited specific cytotoxicity to A549 cancer cells in micromole magnitude than other cancer cells tested and less toxicity than cisplatin for normal human cells HUVEC, in which massive cell apoptosis was induced by complexes through producing DNA damage and suppressing DNA synthesis.Communicated by Ramaswamy H. Sarma.

Entities:  

Keywords:  A549 cell; DNA interaction; HSA binding; Lanthanide-based anticancer agent; hydrazine

Mesh:

Substances:

Year:  2019        PMID: 30806572     DOI: 10.1080/07391102.2019.1587511

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  3 in total

1.  Synthesis, Characterization and Biological Activities of New Schiff Base Compound and Its Lanthanide Complexes.

Authors:  Abdel-Aziz Abu-Yamin; Maisa Siddiq Abduh; Sultan Ayesh Mohammed Saghir; Naif Al-Gabri
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-07

2.  Parent and nano-encapsulated ytterbium(iii) complex toward binding with biological macromolecules, in vitro cytotoxicity, cleavage and antimicrobial activity studies.

Authors:  Zahra Aramesh-Boroujeni; Shohreh Jahani; Mozhgan Khorasani-Motlagh; Kagan Kerman; Meissam Noroozifar
Journal:  RSC Adv       Date:  2020-06-17       Impact factor: 4.036

3.  Enhancement of Cisplatin Cytotoxicity by Cu(II)-Mn(II) Schiff Base Tetradentate Complex in Human Oral Squamous Cell Carcinoma.

Authors:  Rasha H Al-Serwi; Gamal Othman; Mohammed A Attia; Eman T Enan; Mohamed El-Sherbiny; Seham Mahmoud; Nehal Elsherbiny
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.